Full-Time

Project Manager

Life Science

Deadline 5/28/27
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

1,001-5,000 employees

Integrated design, engineering, construction management

No salary listed

Mumbai, Maharashtra, India + 2 more

More locations: Hyderabad, Telangana, India | New Delhi, Delhi, India

In Person

Bachelor's

Category
Biology & Biotech (1)
Business & Strategy (1)
Required Skills
GMP
Risk Management

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Requirements
  • A minimum of 12 years of industry experience, including at least five years of project delivery experience.
  • A bachelor's degree in engineering, architecture, or planning.
  • A minimum of five years of pharmaceutical project experience.
  • Progressive ability, capacity, and aptitude in administration to plan, organize, supervise, and coordinate technical work and obtain cooperation from others.
  • Fundamental scheduling skills.
  • Good written and verbal communication skills.
  • Analytical thinking, structured problem-solving skills, team-building ability, strong work ethic, and the ability to build rapport with project staff.
  • Proficiency with information technology tools, including spreadsheets, word processing, and planning and scheduling software.
  • Understanding of earned value and other project controls methods.
  • Promotion of safety and adherence to IPS and client safety policies.
Responsibilities
  • Own the end-to-end project delivery lifecycle from initiation to handover for life sciences projects, ensuring delivery within defined scope, timelines, budgets, and quality standards.
  • Serve as the single point of accountability for delivery performance while managing internal teams, subcontractors, and client expectations.
  • Participate in pre-bid meetings, support proposal development, and align project goals with client and corporate objectives.
  • Lead or contribute to design development and budget planning activities with minimal supervision.
  • Build and maintain client relationships within the pharmaceutical, biotechnology, and research and development industries, acting as a trusted advisor.
  • Identify delivery risks early, escalate appropriately, and work with project executives and directors to implement mitigation strategies.
  • Oversee change-control processes, including communication and documentation of scope adjustments and additional service needs.
  • Direct multidisciplinary teams and subcontractors across engineering, construction, commissioning, and validation phases.
  • Drive adherence to project governance, compliance requirements such as good manufacturing practices, the Food and Drug Administration, and the Medicines and Healthcare products Regulatory Agency, and documentation standards.
  • Maintain and update project execution plans, meeting minutes, action-item logs, and status dashboards.
  • Prepare and present internal and client-facing financial and schedule reports, flagging variances and recommending corrective actions.
  • Ensure consistent team communication, coordination, and accountability across stakeholders.
  • Manage subconsultant scopes related to cleanrooms, critical utilities, process equipment, and validation.
  • Deliver multiple concurrent large life sciences projects in a fast-paced environment.
  • Promote continuous learning and innovation in delivery methodologies by leveraging tools and standard operating procedures for process improvement.
  • Provide mentorship and leadership to project managers, engineers, and support staff.
  • Take proactive ownership of delivery outcomes, resolve conflicts, and prevent delays through foresight and engagement.
  • Identify and implement best practices and innovations to improve operational efficiency, compliance, and client satisfaction.
  • Perform additional duties as required in support of strategic business goals.
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

View

IPS provides design, engineering, and construction management for complex facilities, especially in the pharmaceutical and biotech industries. Its products work by integrating these services into one team from the project’s start, coordinating planning, detailed design, procurement, and construction management to align with a client's business goals and move a project from concept to operational facility. The company differentiates itself through integrated delivery across disciplines and a global footprint (five continents), supported by growth through strategic acquisitions and Berkshire Hathaway backing, which adds financial strength and scale. IPS’s goal is to help life-science clients bring critical facilities online efficiently, with predictable cost, schedule, and quality, by delivering coordinated design, engineering, and construction management under one umbrella.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Philadelphia, Pennsylvania

Founded

1989

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GE HealthCare named IPS lead on its Cork expansion on January 31, 2025.
  • BeiGene's $800 million Hopewell facility completed in January 2025, proving delivery at scale.
  • Revelio Labs showed 7,131 employees in March 2026, with 561 active postings across the business.

What critics are saying

  • Kinetic System v. IPS ended with adverse fee rulings on March 24, 2025, exposing contract friction.
  • IPS remains tied to capital-intensive drug plants; project cancellations quickly crush utilization and margin.
  • If biotech capex freezes through 2026, IPS loses backlog concentration and Berkshire owns a cyclical builder.

What makes IPS-Integrated Project Services, LLC unique

  • IPS integrates EPCMV across pharma and biotech, from concept through final process qualification.
  • Berkshire Hathaway ownership since 2022 gives IPS permanent capital and credibility with large customers.
  • IPS runs 29 offices across 22 countries, supporting global delivery for regulated facilities.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
PR Newswire
Aug 8th, 2025
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer

TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.

IPSDB
Mar 14th, 2025
IPS Expands Leadership in Ireland with Appointment of Karl Page

IPS expands leadership in Ireland with appointment of Karl Page.

HIT Consultant
Feb 25th, 2025
The Future Of Advanced Therapeutics: Opportunities And Challenges

Sai Bhamidipati, Pharmaceutical Regulatory Affairs ConsultantThe biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.mRNA Vaccines: Revolutionizing Disease PreventionMessenger RNA (mRNA) vaccines have gained prominence, particularly during the COVID-19 pandemic, demonstrating the potential for rapid development and high efficacy. Unlike traditional vaccines, which utilize weakened or inactivated pathogens or their protein subunits, mRNA vaccines utilize a synthetic version of the messenger RNA to instruct cells to produce a protein that elicits an immune response. This modality allows for swift adaptation to emerging pathogens and has opened avenues for vaccines targeting various diseases, including influenza and certain types of cancers.Opportunities:Rapid Development: The cell-free, scalable nature of mRNA production enables quick responses to emerging health threats.IPSDBThe cell-free, scalable nature of mRNA production enables quick responses to emerging health threats. IPSDB Versatility: mRNA vaccines can be designed to target a wide range of therapeutic areas, including but not limited to infectious diseases, Cancer-specific antigens, and rare disease areas.Challenges:Manufacturing Complexities: Scaling up production for mass production while maintaining quality and consistency poses significant challenges

IPSDB
Sep 18th, 2024
Kneat and IPS Announce Strategic Partnership

By integrating Kneat's digital validation software with IPS' technology driven delivery approach, a new benchmark for a truly digital integrated project delivery model, from concept/requirements definition through final process qualification.

IPSDB
Jul 11th, 2024
IPS Accelerates Expansion in Switzerland with New Office and Enhanced R&D Capabilities

Additionally, Integrated Project Services, LLC is excited to announce the appointment of Pia Mueller as the new Senior Manager of Laboratory Projects.